Samarasekera, EJ;
Clark, CE;
Kaur, S;
Patel, RS;
Mills, J;
(2023)
Cardiovascular disease risk assessment and reduction: summary of updated NICE guidance.
BMJ
, 381
p1028-p1028.
10.1136/bmj.p1028.
Preview |
Text
Patel_NICE guideline summary BMJ _ 130423.pdf Download (166kB) | Preview |
Abstract
NICE recommendations are based on systematic reviews of the best available evidence and explicit consideration of cost effectiveness. When minimal evidence is available, recommendations are based on the guideline committee's (GC's) experience and opinion of what constitutes good practice. Evidence levels for the recommendations are given in italic in square brackets. Definitions of evidence certainty are given in box 1.
| Type: | Article |
|---|---|
| Title: | Cardiovascular disease risk assessment and reduction: summary of updated NICE guidance |
| Location: | England |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1136/bmj.p1028 |
| Publisher version: | https://doi.org/10.1136/bmj.p1028 |
| Language: | English |
| Additional information: | This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions. |
| Keywords: | Humans, Cardiovascular Diseases, Risk Assessment |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute of Cardiovascular Science UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute of Cardiovascular Science > Population Science and Experimental Medicine |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10175058 |
Archive Staff Only
 |
View Item |
